MedTrace Logo

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

NCT05509543 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-06-20

No results posted yet for this study

Summary

This study evaluate the pharmacokinetic and safety of IY-NT-T in healthy adults

Conditions

  • Pharmacokinetics

Interventions

DRUG

IY-NT-T

Ilaprazole 20mg

DRUG

IY-NT-R

Ilaprazole 10mg

Sponsors & Collaborators

  • Il-Yang Pharm. Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Jae Woo Kim, MD, PhD · H Plus Yangji Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-24
Primary Completion
2022-10-22
Completion
2023-12-18

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05509543 on ClinicalTrials.gov